These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20708408)

  • 41. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4.
    Lee L; Davis R; Vanderham J; Hills P; Mackay H; Brown T; Mooberry SL; Lee M
    Eur J Med Chem; 2008 Sep; 43(9):2011-5. PubMed ID: 18226429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4.
    Nguyen TT; Lomberget T; Tran NC; Colomb E; Nachtergaele L; Thoret S; Dubois J; Guillaume J; Abdayem R; Haftek M; Barret R
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7227-31. PubMed ID: 23063401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
    De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
    J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.
    Stefely JA; Palchaudhuri R; Miller PA; Peterson RJ; Moraski GC; Hergenrother PJ; Miller MJ
    J Med Chem; 2010 Apr; 53(8):3389-95. PubMed ID: 20334421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of novel anticancer bivalent colchicine-tubulizine hybrids.
    Malysheva YB; Combes S; Allegro D; Peyrot V; Knochel P; Gavryushin AE; Fedorov AY
    Bioorg Med Chem; 2012 Jul; 20(14):4271-8. PubMed ID: 22739088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The microtubule-pore gatekeeper.
    Snyder JP
    Nat Chem Biol; 2007 Feb; 3(2):81-2. PubMed ID: 17235340
    [No Abstract]   [Full Text] [Related]  

  • 48. Design, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1,2,3-triazole moiety.
    Thomas KD; Adhikari AV; Shetty NS
    Eur J Med Chem; 2010 Sep; 45(9):3803-10. PubMed ID: 20542604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
    Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
    J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.
    Sun L; Vasilevich NI; Fuselier JA; Hocart SJ; Coy DH
    Bioorg Med Chem Lett; 2004 May; 14(9):2041-6. PubMed ID: 15080975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles.
    Holla BS; Mahalinga M; Karthikeyan MS; Poojary B; Akberali PM; Kumari NS
    Eur J Med Chem; 2005 Nov; 40(11):1173-8. PubMed ID: 15979767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
    McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
    Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
    Woods JA; Hadfield JA; Pettit GR; Fox BW; McGown AT
    Br J Cancer; 1995 Apr; 71(4):705-11. PubMed ID: 7710932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
    Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
    Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
    La Regina G; Edler MC; Brancale A; Kandil S; Coluccia A; Piscitelli F; Hamel E; De Martino G; Matesanz R; Díaz JF; Scovassi AI; Prosperi E; Lavecchia A; Novellino E; Artico M; Silvestri R
    J Med Chem; 2007 Jun; 50(12):2865-74. PubMed ID: 17497841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New para-para stilbenophanes: synthesis by McMurry coupling, conformational analysis and inhibition of tubulin polymerisation.
    Álvarez R; López V; Mateo C; Medarde M; Peláez R
    Chemistry; 2011 Mar; 17(12):3406-19. PubMed ID: 21344518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and synthesis of novel enhanced water soluble hydroxyethyl analogs of combretastatin A-4.
    Lee M; Brockway O; Dandavati A; Tzou S; Sjoholm R; Nickols A; Babu B; Chavda S; Satam V; Hartley RM; Westbrook C; Mooberry SL; Fraley G; Lee M
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2087-91. PubMed ID: 21345671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.
    Pandit B; Hu Z; Chettiar SN; Zink J; Xiao Z; Etter JP; Bhasin D; Li PK
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6902-4. PubMed ID: 24169233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitors.
    Gangjee A; Kurup S; Smith CD
    Bioorg Med Chem; 2013 Mar; 21(5):1180-9. PubMed ID: 23352482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of CYT997: a structurally novel orally active microtubule targeting agent.
    Burns CJ; Harte MF; Bu X; Fantino E; Joffe M; Sikanyika H; Su S; Tranberg CE; Wilson N; Charman SA; Shackleford DM; Wilks AF
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4639-42. PubMed ID: 19616947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.